Tag: phase 2a first-in-human study
Data for the phase 2a first-in-human study of Eyesight RPE for dry AMD will be submitted by Eyestem to DCGI.
The Drugs Controller General of India (DCGI) will receive data from Eyestem for approval of a phase 2a…
